TF ZEB1, which is an important regulator of EMT during embryonic development and cancer progression [59], is modified by phosphorylation to increase its transcriptional activity to downregulate the expression of TGFBR3 and integrate cytokines and growth factors in the local environment of cancer cells [60]. The gene discussed is TF; the disease is cancer.